RESEARCH MONOGRAPH · KDC-MN-127

Thymalin

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

54/100

Russian thymic extract with longevity-cohort data thats hard to interpret but harder to ignore

Thymalin is the polypeptide complex that comes out of the Khavinson school at the St. Petersburg Institute of Bioregulation and Gerontology. It's a bovine thymus extract, not a defined single molecule, which is the first thing to wrestle with. You're working with a mixture of low-molecular-weight peptides that the manufacturers characterize by HPLC fingerprint and biological activity, not by structure.

The reason people pay attention anyway is the Khavinson elderly-cohort studies running back to the 1980s. Twenty-plus year followups in St. Petersburg pensioners with reductions in all-cause mortality versus matched controls. Thats a striking signal even if the methodology has problems (open-label in places, Russian-language reporting, hard to fully audit). The mechanism story is that the peptide fragments restore some thymic function in age-related immune decline, which is plausible given that thymic involution is a real driver of immunosenescence.

What we like: the long-followup human data is rare in this space. Most peptide bioregulators have nothing close. And the thymic-involution problem is real biology, not a hype target.

What we dont like: it's a mixture, and mixtures are murder for reproducibility. Batch-to-batch variation matters in ways you cant fully control. Also the field around Thymalin has gotten tangled with adjacent Khavinson products (Epitalon, Thymogen, Thymulin) where the marketing tries to make them sound like one coherent program when the evidence quality varies wildly between them.

Mechanism is honestly underspecified. Restoring T-cell maturation markers, modulating cytokine balance, but the specific bioactive components and their receptor targets arent fully mapped. This is partly because nobody in the West has invested in deconvoluting it.

Sourcing-wise, this is where it gets hard. The legitimate manufacturer is in Russia, and Western vendors selling Thymalin are often selling something synthesized to match a published amino acid analysis but not validated against the original extract. Treat sourcing carefully here.

Worth studying as a research tool if you care about thymic biology in aging. Not something to evaluate based on Western RCT-style standards, because that data mostly doesnt exist outside the Khavinson universe.

Evidence: 45
Mechanism: 45
Reliability: 50
Safety: 75
Sourcing: 50
Value: 55
Signal: 60
Staying power: 55

Plain-language summary Intrigue 58 / 100

Thymalin is a Russian-developed bovine thymus peptide preparation used as an immunomodulator for elderly patients and immune disorders. Combined with epitalon in Khavinson's longevity research. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Bovine thymus peptide preparation

A bovine thymus peptide complex used in Russian medicine for immunodeficiency and aging-related immune decline.

Abstract

Thymalin is a peptide complex prepared from bovine thymus, used in Russian medicine for primary and secondary immunodeficiency, infectious diseases, and aging-related immune decline. The product is a heterogeneous mixture of low-molecular-weight peptides; biological activity is attributed to multiple components acting in concert. Pharmacology includes T-cell maturation support, modest cytokine modulation, and proposed immunorestorative effects in the elderly. Administered intramuscularly. Russian clinical literature reports modest effects on infection rates and immune endpoint measures in elderly populations. Reported research dose ranges in the literature are 5 to 20 mg intramuscular over short courses.

Mechanism of action

Heterogeneous peptide mixture; T-cell maturation and immunorestorative effects.

Reported research dose ranges

Reported research dose ranges in the literature are 5 to 20 mg intramuscular over short courses.

References

Khavinson VK. Peptide regulation of aging. Russian Academy of Medical Sciences 2000s.

Read the full monograph

The full reference document covers compound identification, discovery and developmental history, mechanism of action, pharmacokinetics, reported research dose ranges, sourcing and quality verification, reconstitution and handling, stack interaction considerations, and a curated reference list. Available as a research-use-only PDF download.

KDC-MN-127

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Thymalin

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs